Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Status:
Completed
Trial end date:
1999-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of isotretinoin may be an effective way to
prevent cancer or stop cancer from growing. Interferon alfa may interfere with the growth of
cancer cells. Combining isotretinoin and interferon may be an effective treatment for some
recurrent cancers.
PURPOSE: Phase II trial to study the effectiveness of interferon alfa plus isotretinoin in
treating patients with recurrent cancer.